HOME › DRUGS › LUMASIRAN
ACTIVE SUBSTANCE / INN

LUMASIRAN

Brand name(s): Oxlumo
EMA LISTED
AUTHORISED
Hyperoxaluria, Primary
ACTIVE SUBSTANCE
Lumasiran
REGULATORS
EMA
SPONSORS / MAH
Alnylam Netherlands B.V.
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
OxlumoAlnylam Netherlands B.V.Authorised19/11/2020Hyperoxaluria, Primary

FULL INTELLIGENCE ON LUMASIRAN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →